Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Krystal Biotech Inc KRYS

Healthcare Biotechnology
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical... see more

Current News (NDAQ:KRYS)

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 7 days ago

Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis

GlobeNewswire 10 days ago

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis

GlobeNewswire 11 days ago

Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 13 days ago

Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference

GlobeNewswire November 26, 2025

Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results

GlobeNewswire November 3, 2025

Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025

GlobeNewswire October 21, 2025

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

GlobeNewswire October 14, 2025

Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label

GlobeNewswire September 15, 2025
View More News ››

Opinion & Analysis (NDAQ:KRYS)

Biotech Reports Encouraging Interim Gene Therapy Data for Skin Disorder

Streetwise Reports October 18, 2018
View More Opinion ››

Bullboard Posts (NDAQ:KRYS)

4 PROMISING BIOTECH STOCKS WITH IMMENSE POTENTIAL!

$CPRX $KRYS $XENE $VBIV   Read on to know more: https://www.aviseanalytics.com/4-promising-biotech-stocks-with...
AviseAnalytics - December 13, 2021

RE:4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION!

Lisagerrard17 - October 15, 2021

4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION!

$KRYS $MTEM $SNDX $STRO Clinical-Stage companies offer an exciting investment opportunity with massive upside potential...
AviseAnalytics - October 5, 2021

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021

test

paths - June 27, 2020
View more Bullboard ››

AKITA Drilling Ltd.

AKITA Drilling Ltd.

AKITA Drilling Ltd. operates as an oil and gas drilling contractor in Canada and the United States. It is involved in the ...
View More »

Podcasts